Literature DB >> 273239

Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle.

J Lindstrom, B Einarson, J Merlie.   

Abstract

Four polypeptide chains were purified from acetylcholine receptor of Torpedo californica electric organ. Their apparent molecular weights were 64,000, 57,000, 49,500, and 38,000. Rats immunized with any of the four chains produced antibodies that crossreacted with rat muscle receptors in vivo. Specificities of anti-chain sera were evaluated in vitro by reaction with native receptor solubilized from electric organs and muscles of several species and by inhibition of this reaction with the purified polypeptide chains. The chains are immunologically distinct from one another. Antigenic determinants comparable to each chain of torpedo receptor are found in receptor from both rat and human muscle. At least part of each of these determinants is exposed on the extracellular surface of the muscle membrane. The most immunogenic determinants on native receptor are lost on denaturation to polypeptide chains. Its component peptides are much less immunogenic than native receptor, and induce antibodies of different specificity. Anti-receptor antibodies of many specificities can cause experimental autoimmune myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 273239      PMCID: PMC411338          DOI: 10.1073/pnas.75.2.769

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.

Authors:  A G Engel; E H Lambert; F M Howard
Journal:  Mayo Clin Proc       Date:  1977-05       Impact factor: 7.616

2.  Subunit structure of the acetylcholine receptor from denervated rat skeletal muscle.

Authors:  S C Froehner; C G Reiness; Z W Hall
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

3.  Purification and characterization of the cholinergic receptor protein in its membrane-bound and detergent-soluble forms from the electric organ of Torpedo marmorata.

Authors:  A Sobel; J P Changeux
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

4.  Purification of an acetylcholine receptor from a nonfusing muscle cell line.

Authors:  J Boulter; J Patrick
Journal:  Biochemistry       Date:  1977-11-01       Impact factor: 3.162

5.  Affinity alkylation labels two subunits of the reduced acetylcholine receptor from mammalian muscle.

Authors:  S C Froehner; A Karlin; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

6.  Molecular forms of acetylcholine receptor. Effects of calcium ions and a sulfhydryl reagent on the occurrence of oligomers.

Authors:  H W Chang; E Bock
Journal:  Biochemistry       Date:  1977-10-04       Impact factor: 3.162

7.  Immunological comparison of acetylcholine receptors and their subunits from species of electric ray.

Authors:  T Claudio; M A Raftery
Journal:  Arch Biochem Biophys       Date:  1977-06       Impact factor: 4.013

8.  Modulation of acetylcholine receptor by antibody against the receptor.

Authors:  S Heinemann; S Bevan; R Kullberg; J Lindstrom; J Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.

Authors:  S H Appel; R Anwyl; M W McAdams; S Elias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

10.  Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-04-29       Impact factor: 47.728

View more
  26 in total

1.  Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.

Authors:  Jie Luo; Alexander Kuryatov; Jon M Lindstrom
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

Review 2.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Synthesis of an antigenic site of native acetylcholine receptor peptide 159-169 of Torpedo acetylcholine receptor alpha-chain.

Authors:  D J McCormick; V A Lennon; M Z Atassi
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

6.  Structural basis for α-bungarotoxin insensitivity of neuronal nicotinic acetylcholine receptors.

Authors:  Steven M Sine; John R Strikwerda; Simone Mazzaferro
Journal:  Neuropharmacology       Date:  2019-06-01       Impact factor: 5.250

7.  Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.

Authors:  Jie Luo; Palmer Taylor; Mario Losen; Marc H de Baets; G Diane Shelton; Jon Lindstrom
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

Review 8.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

9.  Myasthenogenicity of the main immunogenic region.

Authors:  Jon Lindstrom; Jie Luo
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

10.  Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.

Authors:  Jon Lindstrom; Jie Luo; Alexander Kuryatov
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.